Emergent Health Corp. (PN) Stock Price - EMGE

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$44.59
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
SMALL CAP BASIC
Monthly Subscription
for only
$30.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Emergent Health Corp. (PN) EMGE Other OTC Common Stock Emergent Health Corp New
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.03 -21.74% 0.108 0.108 0.035 0.035 0.138 16:12:27
Bid Price Ask Price Spread Spread % News
0.0002 2 1.9998 99.99% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 210 $ 0.0698 $ 14.65002 987 0.0000 - 0.21
Last Trade Time Type Quantity Stock Price Currency
09:49:09 100 $0.11 USD

Emergent Health Corp. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.3M 39.8M - - 4.08M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Emergent Health Corp. (PN) News

Real-Time news about Emergent Health Corp. (PN) (Other OTC): 0 recent articles

Latest EMGE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EMGE Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.04750.1480.0350.1414836503270.0605127.37%
1 Month0.0740.21050.0350.1779223k7210.03445.95%
3 Months0.0350.21050.0350.08302216k2k0.073208.57%
6 Months0.0096380.21050.00750.03892246k5k0.0983621,020.56%
1 Year0.02170.21050.0000010.0246193k6k0.0863397.70%
3 Years0.220.2250.0000010.0394193k4k-0.112-50.91%
5 Years0.132.10.0000010.2176193k4k-0.022-16.92%

Emergent Health Corp. (PN) Description

Emergent Health Corp. engages in the discovery, development and marketing of products designed to better mankind. Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third party label exemptions. Emergent is focusing current efforts on marketing licensed patent pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Emergent is also licensed under a patent pending application to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and Professional markets. Research and Development is exploring other areas such as Secretogues that can naturally enhance a person's own Growth Hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, legally and utilizing known body mechanisms without the use of drugs. Emergent does not claim any of its products diagnose, treat, cure or prevent any disease. Emergent was founded in 2006 and is now headquartered in King of Prussia, PA.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180721 13:43:02